To address this question, we analysed the mRNA levels of the lipid metabolism biomarkers SREBF1, FASN, SCD, LDLR, CD36, LPL, FABP1, FABP4, ABCA1, APOA1, and AGPAT1 in actual tumoural tissue samples by meta-analysis of the COAD TCGA dataset, to determine their usefulness as prognostic markers. The gene discussed is CD36; the disease is neoplasm.